Free Trial
NASDAQ:PULM

Pulmatrix (PULM) Stock Price, News & Analysis

Pulmatrix logo
$6.79 -0.21 (-2.94%)
As of 07/3/2025 01:28 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Pulmatrix Stock (NASDAQ:PULM)

Key Stats

Today's Range
$6.52
$6.91
50-Day Range
$6.08
$9.09
52-Week Range
$1.78
$10.40
Volume
15,696 shs
Average Volume
137,964 shs
Market Capitalization
$24.80 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PULM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pulmatrix and its competitors with MarketBeat's FREE daily newsletter.

PULM Stock News Headlines

Pulmatrix Inc.
Trump’s Exec Order #14154 could be a “Millionaire-Maker”
Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.” We recently sat down with Rickards to capture all the key details on tape.
See More Headlines

PULM Stock Analysis - Frequently Asked Questions

Pulmatrix's stock was trading at $6.98 on January 1st, 2025. Since then, PULM stock has decreased by 2.7% and is now trading at $6.7940.

Pulmatrix, Inc. (NASDAQ:PULM) released its quarterly earnings results on Thursday, May, 15th. The biotechnology company reported ($0.50) earnings per share (EPS) for the quarter. Pulmatrix had a negative net margin of 122.46% and a negative trailing twelve-month return on equity of 94.97%.

Pulmatrix shares reverse split on the morning of Tuesday, March 1st 2022.The 1-20 reverse split was announced on Tuesday, March 1st 2022. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, March 1st 2022. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Shares of PULM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Pulmatrix investors own include NVIDIA (NVDA), CymaBay Therapeutics (CBAY), GE Aerospace (GE), Meta Platforms (META), Advanced Micro Devices (AMD), Broadcom (AVGO) and Adobe (ADBE).

Company Calendar

Last Earnings
5/15/2025
Today
7/05/2025
Next Earnings (Estimated)
8/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:PULM
Employees
20
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$6.94 million
Net Margins
-122.46%
Pretax Margin
-498.39%

Debt

Sales & Book Value

Annual Sales
$7.81 million
Price / Cash Flow
N/A
Book Value
$2.45 per share
Price / Book
2.77

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
1.36

Social Links

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (NASDAQ:PULM) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners